Samsung C&T Q1 2026 Strong Earnings, Enhanced Shareholder Return Policy
- Revenue 10.47T KRW, operating profit 724B KRW, net profit 1.09T KRW (consolidated). Balanced growth across construction, trading, and bio segments.
- Bio segment sales 1.44T KRW, operating profit 484B KRW. Samsung Biologics Plant 4 operation and HGS acquisition completed.
- New shareholder return policy (2026-2028): minimum DPS raised from 2,000 to 2,500 won, maintain 60-70% payout of affiliate dividends.
- Canceled 7,807,563 treasury shares on March 13, 2026. Additional cancellation approved at AGM.
- Construction order backlog 31.7T KRW (total contracted 92.4T KRW); major projects on track.
- Debt-to-equity ratio 49.9% (debt 35T/equity 70T), sound financial structure.
- Litigation and contingent liabilities not expected to materially impact financial statements.
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Quarterly Report (2026.03)
- Company: Samsung C&T (028260)
- Submission: Samsung C&T Corporation
- Receipt: 05-15-2026